Skip to main content

A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis

Completed · Phase 4 · NCT03915964

Conditions: Rheumatoid Arthritis

At a glance

Research payments reported, 2025
$726,211
U.S. investigators named
56
Sites paid
46
Planned or actual enrollment
2,659

About the trial

Sponsor
Eli Lilly and Company (with Incyte Corporation)
Tested
Baricitinib (drug), TNF Inhibitor (drug)
Dates
Started 2019-04-25; completion 2025-05-28
Results posted
Yes

This post-marketing study is designed to compare the safety of baricitinib versus tumor necrosis factor (TNF) inhibitors with respect to venous thromboembolic events (VTEs) when given to participants with rheumatoid arthritis.

From ClinicalTrials.gov, last updated 2026-06-24. Full record, eligibility and contacts (opens in a new tab)

Industry funding

Eli Lilly and Company reported $726,211 in research payments for this study in 2025 (99 payments).

Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.

U.S. investigators named on this study

Clinicians the company named as principal investigators in its Open Payments reports.

Sites paid to run it

  • Interspond LLC $62,466
  • Biovin Enterprises LLC $60,322
  • Dynamed Clinical Research LP, DBA Dm Clinical Research $56,370
  • Piedmont Medical Research Associates Inc $46,831
  • Arizona Arthritis and Rheumatology Research $46,826
  • Paramount Medical Research and Consulting $39,543
  • St Jude Heritage Healthcare $29,821
  • Neuwelt Michael C MD Inc $28,712
  • Amarilis Perez $28,460
  • Altoona Center for Clinical Research PC $26,204
  • Accurate Clinical Research Inc $21,554
  • Physicians Research Collaboration $21,155
  • Mary Hitchcock Memorial Hospital, NH $20,979
  • Logan Health Medical Center, MT $19,403
  • Rheumatology Center of San Diego PC $18,147
  • Gcm Medical Group Psc $17,517
  • Clinical Trials of Texas Inc $17,168
  • Irvine Center for Clinical Research Inc $14,988
  • Mindful Medical Research $14,602
  • Qualmedica Research LLC $13,559
  • Accurate Clinical Management LLC $11,550
  • Newport Huntington Medical Group $11,091
  • Iris Rsrch and Development $11,022
  • Suncoast Clinical Research $10,747
  • Albuquerque Center for Rheumatology $10,478
  • Advanced Rheumatology PC $8,592
  • Clinvest Headlands LLC $6,567
  • Oklahoma Medical Research Foundation $6,215
  • Camc Health Education and Research Institute Inc $5,965
  • Cleveland Clinic, OH $5,955
  • St Luke's Regional Medical Center, ID $5,637
  • Biopharma Informatic Inc Research Center $5,118
  • Latin Clinical Trial Center Inc $4,745
  • Neccr Prima Care Research LLC $3,170
  • Forward Clinical Trials Inc $3,125
  • Vancouver Clinic Inc Ps $2,780
  • Arthritis Northwest PLLC $2,422
  • Desert Medical Advances $2,145
  • Inland Empire Liver Foundation $1,309
  • Regents of the University of California $1,078
  • East Penn Rheumatology Associates PC $1,020
  • Inland Rheumatology Clinical Trials Inc $469
  • Dermatology Cente for Skin Health $164
  • Acn Research LLC $111
  • Hoag Memorial Hospital Presbyterian $65
  • St Lukes Clinic $44

Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.